Science & Enterprise subscription

Follow us on Twitter

  • New post on Science and Enterprise: Editorial Posts Resume Tomorrow https://t.co/ZTVMsYlwg8 #Science #Business
    about 7 hours ago
  • As mobile phones, smart watches, and tablets play an increasingly key role in our daily lives, a new report shows m… https://t.co/HNOl3qa4oI
    about 2 days ago
  • New post on Science and Enterprise: Infographic – Mobile Industry’s Economic Role https://t.co/aMBZtn0gkM #Science #Business
    about 2 days ago
  • FDA expert panel gives thumbs-up to Aimmune’s peanut allergy drug https://t.co/srCucGLuB5
    about 3 days ago
  • A developer of a drug for migraine formulated as a dry powder and given as a nasal spray is raising $82.5 million i… https://t.co/gn4NSNTmBR
    about 3 days ago

Please share Science & Enterprise

Carb-X Funds Drug-Resistant Bacterial Vaccine

Klebsiella pneumoniae

A company developing vaccines with synthetic biology is receiving a grant for a vaccine to prevent infections from drug-resistant Klebsiella pneumoniae bacteria. . . . → Read More: Carb-X Funds Drug-Resistant Bacterial Vaccine

FDA Okays Celiac Disease Engineered Microbe Trial

fresh bread

A company making synthetic biological therapies received authorization to begin clinical trials in the U.S. for an engineered microbe to treat celiac disease. . . . → Read More: FDA Okays Celiac Disease Engineered Microbe Trial

Controlled Brain Tumor Gene Therapy Shown Safe

Brain tumor graphic

A clinical trial shows an experimental gene therapy that controls release of a powerful anti-tumor protein is safe for patients with stubborn glioblastoma, a type of brain cancer. . . . → Read More: Controlled Brain Tumor Gene Therapy Shown Safe

Trial Shows Two Drugs Can Treat Ebola Virus

Ebola virus

A clinical trial in the Congo shows two different therapies made with synthetic antibodies are better able to treat Ebola infections than two other drugs tested. . . . → Read More: Trial Shows Two Drugs Can Treat Ebola Virus

Engineered Bacteria Hydrogels Designed for Gut Repair

Nanofibers from engineered E. coli

Biomedical engineers genetically altered bacteria that when added to gel materials can be applied like a spray or ointment to help heal intestinal surfaces. . . . → Read More: Engineered Bacteria Hydrogels Designed for Gut Repair

MD Anderson, Drug Maker Partner on Lung, GI Cancers

Cancer magnified

MD Anderson Cancer Center and drug maker Boehringer Ingelheim agreed to jointly develop new treatments for lung and gastrointestinal cancers. . . . → Read More: MD Anderson, Drug Maker Partner on Lung, GI Cancers

Food Technology Company Gains $4M in Seed Funds

Cut oranges and grapefruit

A company developing a food preservation technology from university materials science labs is raising $4 million in its seed funding round. . . . → Read More: Food Technology Company Gains $4M in Seed Funds

FDA Investigating Data Manipulation in Gene Therapy Approval

Magnify facts

The Food and Drug Administration is investigating manipulation of preclinical tests submitted for its approval of a gene therapy to treat a rare disease. . . . → Read More: FDA Investigating Data Manipulation in Gene Therapy Approval

Company Forms to Treat Vaginal Microbial Disorders

Lactobacillus

A new enterprise has launched to develop live microbial treatments for urinary tract infections and other diseases originating in vaginal bacterial communities. . . . → Read More: Company Forms to Treat Vaginal Microbial Disorders

Nanotech Vaccine Aids Melanoma Immunotherapy

Ronit Satchi-Fainaro

A vaccine made with nanoscale peptide particles can prevent the occurrence of melanoma in lab mice, and treat the condition when combined with other drugs. . . . → Read More: Nanotech Vaccine Aids Melanoma Immunotherapy